How it works, simply
It activates two receptors involved in appetite and metabolism.
What the evidence tells us
Approval in one country is not approval in every country; check the exact product and indication.
Approved use: China: adult chronic weight management and type 2 diabetes, according to the sponsor. This does not represent US FDA approval.
Watch with PEP 7
A short introduction; the sources and limitations remain important.
Open video guide
Video guides are coming soon.
Risks and open questions
This brief guide does not summarize every contraindication or interaction. Use the current label for the exact product; the label directory is linked below.
Research and education only. PepGuide does not recommend medicines, doses or protocols.
Technical details and study context
Mechanism: Activates glucagon and GLP-1 receptors.
Sponsor or developer: Innovent Biologics
Studied or labeled topics: Obesity, Type 2 diabetes
2026-06-06: Sponsor describes Chinese adult weight-management and type 2 diabetes approvals; adolescent use remains investigational.
Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.
Sources and review dates
- Innovent: mazdutide development and approved indications ↗ · Sponsor · 2026-06-06
Readability updated October 10, 2026. Evidence review: September 23, 2026 (listed facts only). A wording update is not a new clinical review.